Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4

Naltrexone as an Adjunct in Alcoholic Cocaine Dependent Patients

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00000307

Enrollment

Registered

1999-09-21

Start date

2003-04-30

Completion date

2007-04-30

Last updated

2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol-Related Disorders, Cocaine-Related Disorders

Keywords

alcohol dependence

Brief summary

The purpose of this study is to evaluate naltrexone as an adjunct in alcoholic cocaine dependent patients; concurrent relapse prevention theory.

Interventions

DRUGNaltrexone

Study design

Primary purpose

TREATMENT

Eligibility

Sex/Gender

ALL

Age

18 Years to 50 Years

Healthy volunteers

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

Measure	Time frame
Verified abstinence from cocaine	over the 12 weeks of study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026